Irene A Abela Selected Research

2019-nCoV Vaccine mRNA-1273

1/2022

Antibody Response in Immunocompromised Patients After the Administration of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccine BNT162b2 or mRNA-1273: A Randomized Controlled Trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Irene A Abela Research Topics

Disease

6	Infections 05/2022 - 02/2018
4	COVID-19 01/2022 - 03/2021
1	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2022
1	Hepatitis C 01/2022
1	Viremia 01/2022
1	Critical Illness (Critically Ill) 01/2022
1	Ataxia (Dyssynergia) 03/2021
1	HIV Infections (HIV Infection) 01/2010
1	Neoplasms (Cancer) 01/2010
1	Autoimmune Diseases (Autoimmune Disease) 01/2010
1	Virus Diseases (Viral Diseases) 01/2010

Drug/Important Bio-Agent (IBA)

4	VaccinesIBA 05/2022 - 01/2019
2	AntibodiesIBA 01/2022 - 01/2010
2	Pharmaceutical PreparationsIBA 01/2022 - 01/2010
1	Neutralizing AntibodiesIBA 01/2022
1	BNT162 VaccineIBA 01/2022
1	2019-nCoV Vaccine mRNA-1273IBA 01/2022
1	Antiviral Agents (Antivirals)IBA 01/2022
1	AutoantibodiesIBA 01/2022
1	Immunoglobulin G (IgG)IBA 01/2022
1	Interferon Type IIBA 01/2022
1	SteroidsIBA 01/2022
1	COVID-19 VaccinesIBA 10/2021
1	mRNA VaccinesIBA 10/2021
1	Methylprednisolone FDA LinkGeneric 03/2021
1	Adrenal Cortex Hormones (Corticosteroids)IBA 03/2021
1	RNA (Ribonucleic Acid)IBA 03/2021
1	Broadly Neutralizing AntibodiesIBA 01/2019

Therapy/Procedure

3	Therapeutics 01/2022 - 01/2010
1	Transplantation 02/2018
1	Lung Transplantation 02/2018